Response to apomorphine in early Parkinson's disease

被引：0
|
作者：
Vitale, C
Marconi, R
Pellecchia, MT
Amboni, M
Bonavita, V
Barone, P
机构：
来源：
MOVEMENT DISORDERS | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P725
引用
收藏
页码：S254 / S254
页数：1
相关论文
共 50 条
  • [31] Levodopa Response in Early Parkinson's Disease
    Hauser, Robert A.
    Auinger, Peggy
    Oakes, David
    MOVEMENT DISORDERS, 2009, 24 (16) : 2328 - 2336
  • [32] Motor response to apomorphine in patients with Parkinson's disease with long-duration response to levodopa
    Bonuccelli, U
    Napolitano, A
    Del Dotto, P
    Quattrone, A
    CLINICAL NEUROPHARMACOLOGY, 2002, 25 (02) : 119 - 121
  • [33] Early factors for predicting discontinuation to subcutaneous Apomorphine infusion in Parkinson's disease: A prospective analysis of the Thai Apomorphine Registry
    Phokaewvarangkul, Onanong
    Anan, Chanawat
    Phimpha, Aukkritthiwat
    Chaudhuri, K. Ray
    van Laar, Teus
    Bhidayasiri, Roongroj
    PARKINSONISM & RELATED DISORDERS, 2021, 91 : 146 - 151
  • [34] Gait and freezing in advanced Parkinson's disease:: Response to pulsatile subcutaneous apomorphine stimulation
    Vaamonde, J
    Ibáñez, R
    Flores, JM
    María, G
    Fontán, C
    Hernández, A
    MOVEMENT DISORDERS, 2005, 20 : S68 - S68
  • [35] Apomorphine infusion and the long-duration response to levodopa in advanced Parkinson's disease
    Stocchi, F
    Berardelli, A
    Vacca, L
    Barbato, L
    Monge, A
    Nordera, G
    Ruggieri, S
    CLINICAL NEUROPHARMACOLOGY, 2003, 26 (03) : 151 - 155
  • [36] Response of tremor to subcutaneous apomorphine in patients with tremor predominant idiopathic Parkinson's disease
    Hellmann, M
    Sabach, T
    Melamed, E
    Djaldetti, R
    MOVEMENT DISORDERS, 2004, 19 : S147 - S147
  • [37] Increasing placebo response in Parkinson's disease through apomorphine pre-conditioning
    Frisaldi, E.
    Carlino, E.
    Giudetti, L.
    Pampallona, A.
    Zibetti, M.
    Lanotte, M.
    Lopiano, L.
    Benedetti, F.
    MOVEMENT DISORDERS, 2016, 31 : S413 - S414
  • [38] Intermittent subcutaneous apomorphine in advanced Parkinson's disease
    Storch, A
    PSYCHOPHARMAKOTHERAPIE, 2005, 12 (01): : 17 - 22
  • [39] Apomorphine: Its value in managing Parkinson's disease
    Macnamara, L
    Sharma, J
    MOVEMENT DISORDERS, 2002, 17 : S69 - S70
  • [40] Apomorphine in Parkinson's Disease-The Questions Raised
    Dhamija, Rajinder K.
    Srivastava, Achal K.
    Garg, Divyani
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2020, 23 (03) : 377 - +
12345